Effect of a glucagon receptor antibody (REMD‐477) in type 1 diabetes: A randomized controlled trial
2018 ◽
Vol 20
(5)
◽
pp. 1302-1305
◽
2006 ◽
Vol 32
(2)
◽
pp. 194-205
◽
Keyword(s):